Screener
Cronos Group
CRONCronos Group is an innovative global cannabinoid company focused on advancing cannabis research, technology, and product development.
Earnings
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$49.5M
EPS estimate$0.03
Segments
By product
Competitors
By market cap
By revenue growth
Profile
Cronos Group is an innovative global cannabinoid company focused on advancing cannabis research, technology, and product development. The company builds and manages a diverse portfolio of international brands across adult-use and medical markets. Its core value proposition centers on creating disruptive intellectual property and maintaining a global distribution network to responsibly elevate the consumer experience.
Competitive position
Cronos is a well-capitalized global player supported by a strategic investment from Altria, focusing on premium brand differentiation and IP-driven product innovation.
GeographiesCanada, Israel, Germany, United Kingdom, Australia, Switzerland
Customer segmentsGovernment Agencies, Medical Patients, Retail Consumers
Business modelManufacturing, Wholesale, Licensing and IP, Direct-to-Patient
SuppliersAgricultural inputs, Greenhouse infrastructure, Laboratory testing services, Third-party cannabis flower suppliers
CustomersOntario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission, Medical pharmacies, Private cannabis retailers
CountryCanada
Listed2016
Employees356.0
CEOMichael Ryan Gorenstein
SectorHealthcare
Websitethecronosgroup.com
FilingsSEC EDGAR
FAQ
- What is Cronos Group's market cap?
- Cronos Group (CRON) has a market capitalization of $1.2B and trades on NASDAQ.
- What is Cronos Group's revenue and profitability?
- Cronos Group generated $179.1M in trailing twelve-month revenue with net income of $70.0M, representing a net margin of 39.1%. Gross margin stands at 45.9%, with free cash flow of $49.8M. The latest reported period is Q2 2026.
- Who are Cronos Group's competitors?
- Cronos Group's key competitors include Canopy Growth Corporation, Tilray Brands, Inc., Aurora Cannabis Inc., and others. These companies compete in similar markets and product categories.
- Who does Cronos Group partner with?
- Cronos Group's notable partners include Altria Group, Inc., Cansativa, Ginkgo Bioworks Holdings, Inc., and others.
- What subsidiaries does Cronos Group have?
- Cronos Group's subsidiaries include Peace Naturals Project Inc., Cronos GrowCo, Cronos Israel.
- Where is Cronos Group headquartered?
- Cronos Group is headquartered in Canada and employs approximately 356 people. It has been publicly traded since 2016.
